PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-65.79%
Negative G&A growth (overhead reduction) needs verification. Benjamin Graham would examine impact on operations.
No Data
No Data available this quarter, please select a different quarter.
143.99%
Other expenses growth above 20% signals concerning cost expansion. Seth Klarman would scrutinize unusual items.
-60.41%
Negative operating expenses growth needs verification. Benjamin Graham would examine sustainability.
-60.41%
Negative total costs growth needs verification. Benjamin Graham would examine sustainability.
2.95%
Interest expense growth 0-5% reflects moderate increase. Benjamin Graham would check leverage ratios.
-100.00%
Negative D&A growth needs verification. Benjamin Graham would examine asset reduction strategy.
-109.95%
Negative EBITDA growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
62.96%
Operating income growth above 15% demonstrates exceptional core profitability. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-184.33%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
47.99%
Pre-tax income growth above 15% demonstrates exceptional profitability improvement. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
387.82%
Tax expense growth above 20% signals concerning expansion. Seth Klarman would scrutinize tax strategy.
53.00%
Net income growth above 15% demonstrates exceptional bottom-line expansion. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
52.84%
EPS growth above 15% demonstrates exceptional shareholder value creation. Warren Buffett would verify sustainability.
52.84%
Diluted EPS growth above 15% demonstrates exceptional value creation despite potential dilution. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.